Advanced search
Publication Cover
Journal of Chemotherapy Volume 33, 2021 - Issue 8
Submit an article Journal homepage
288
Views
4
CrossRef citations to date
0
Altmetric
Anticancer Original Research Papers

Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells

Aykut ÖzgürArtova Vocational School, Department of Veterinary Medicine, Laboratory and Veterinary Health Program, Tokat Gaziosmanpaşa University, Tokat, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4457-1249View further author information
ORCID Icon
Pages 554-563 | Received 25 Nov 2020, Accepted 19 Mar 2021, Published online: 02 Apr 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Aykut Özgür, Özlem Kaplan, Nazan Gökşen Tosun, İbrahim Türkekul & İsa Gökçe. (2023) Green synthesis of silver nanoparticles using Macrolepiota procera extract and investigation of their HSP27, HSP70, and HSP90 inhibitory potentials in human cancer cells. Particulate Science and Technology 41:3, pages 330-340.
Read now

Articles from other publishers (3)

So Yeong Cheon & Sunghark Kwon. (2023) Molecular Anatomy of the EML4-ALK Fusion Protein for the Development of Novel Anticancer Drugs. International Journal of Molecular Sciences 24:6, pages 5821.
Crossref
Kamil Jozef Synoradzki, Ewa Bartnik, Anna M. Czarnecka, Michał Fiedorowicz, Wiktoria Firlej, Anna Brodziak, Agnieszka Stasinska, Piotr Rutkowski & Paweł Grieb. (2021) TP53 in Biology and Treatment of Osteosarcoma. Cancers 13:17, pages 4284.
Crossref
Aykut Özgür, Altan Kara, Nazan Gökşen Tosun, Şaban Tekin & İsa Gökçe. (2021) Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines. Molecular Biology Reports 48:4, pages 3439-3449.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.